New Institute of Medicine Report on Molecular Biomarkers.

In recognition of the expanding field of precision medicine and the desire to give the right person the right medicine at the right time, the National Academies of Sciences, Engineering, and Medicine took up the task of making recommendations about molecular biomarkers. The consensus committee met throughout 2015 and released the report ‘‘Biomarker Tests for Molecularly Targeted Therapies: Key to Unlocking Precision Medicine’’ (National Academies of Sciences, Engineering, and Medicine, 2016) on March 4, 2016. As a result of their consensus study, the committee stated 10 goals and associated recommendations. These address clinical practice, regulatory and reimbursement policy, and data challenges through the framework of a rapid learning system. The 10 goals are as follows: